What do we know for sure about bipolar disorder?

American Journal of Psychiatry

Volumn 162, Issue 1, 2005, Pages 1-2

  Fawcett, Jan ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; METHYLPHENIDATE; PROTEIN P50; VALPROATE SEMISODIUM;

ACTIMETRY; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUDITORY STIMULATION; BIPOLAR DISORDER; CHROMOSOME 12Q; CHROMOSOME 15; COGNITIVE THERAPY; COMORBIDITY; DARIER DISEASE; DISEASE SEVERITY; DISEASE TRANSMISSION; EDITORIAL; GENE LOCUS; HUMAN; INSOMNIA; MOOD DISORDER; PEDIGREE; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SKIN DISEASE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; COMORBIDITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE;

EID: 11844280285     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.1.1     Document Type: Editorial

References (3)

1. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, Endicott J, Keller M: Long-term symptomatic status of bipolar I vs bipolar II disorder. Int J Neuropsychopharmacol 2003; 6:127-137
2. Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H: Recurrence of bipolar disorders and major depression: a life-long perspective. Eur Arch Psychiatry Clin Neurosci 2003; 253:236-240
3. Angst F, Stassen HH, Clayton PJ, Angst J: Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68:167-181